HQL News and Press, TeklaLife Sciences Investors From 02/19/21

PCEF facts and performance. Comparing PCEF with my CEF benchmark. Scanning the PCEF portfolio. A different way to invest in CEFs. For further details see: Why I Won't Touch PCEF With A 10-Foot Pole

Tekla Life Sciences (HQL) declares $0.43/share dividend.Payable March 31; for shareholders of record March 26; ex-div Feb. 25.See HQL Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Tekla Life Sciences declares $0.43 dividend

Risk assets continued their historic run last week with EM equities and commodities leading the way. Bonds sold off as the 10-year Treasury note yield broke above 1.20% for the first time since the lows last spring. The 10-year TIPS yield closed the week at 1.02%, near the all-tim...

After a dramatic year of volatility, the U.S. stock market ended 2020 at record highs. Can this momentum continue this year? ESG investments clearly outperformed in 2020. 2021 should be a year of much better cash flow for companies. For further details see: A Stock Picke...

2020 was a busy year for global healthcare with unprecedented efforts to develop vaccines, treatments, and diagnostics for COVID-19. Deal flow in the sector continued to gain momentum in 2020, with M&A transactions and product licensing deals totalling five-year highs as large-cap...

HQH offers investors a managed quarterly distribution based on 2% of the NAV. The fund's discount has been tightening lately, but is still attractive for long-term investors. The healthcare exposure provides for a mixture of recession-resistant investments that worked especially w...

HQL has outperformed other healthcare-oriented CEFs over the past year. It's selling at a -7.27% discount to NAV. It yields 7.94%, and is a good watchlist candidate. For further details see: Tekla Life Sciences Investors: 8% Yield, 7% Discount

Recent positive developments in COVID-19 vaccines have spurred a wave of market exuberance, lifting share prices of biotech companies at the forefront of the vaccine race. COVID-19 and the urgency to find a cure have opened up opportunities, making the biotech sector a prospective spa...

Tekla Life Sciences (HQL) declares $0.02/share special dividend.Payable Jan. 6; for shareholders of record Dec. 31; ex-div Dec. 30.See HQL Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Tekla Life Sciences declares $0.02 special dividend

On December 21, 2020, Tekla Life Sciences Investors declared a special cash distribution of $0.02 per share in order to satisfy annual tax distribution requirements. The record date for the distribution is December 31, 2020 and the payable date is January 6, 2021. The Fund will trade ex...